Medicare Enrolled
Dr. Spencer Kozinn, M.D.
Student in an Organized Health Care Education/Training Program · Atlanta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kozinn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kozinn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kozinn
Dr. Spencer Kozinn is a student in an organized health care education/training program specialist in Atlanta, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kozinn performed 1,577 Medicare services across 1,218 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kozinn received a total of $16,507 from 59 pharmaceutical and/or device companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kozinn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 12% volume in GA
$16,507 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,577
Medicare services
Top 12% in GA for student in an organized health care education/training program
1,218
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
415 | $88 | $370 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
188 | $0 | $3 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
141 | $122 | $561 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
135 | $179 | $652 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
79 | $55 | $253 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 60 | $133 | $771 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
52 | $31 | $155 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
50 | $181 | $861 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
50 | $108 | $437 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
47 | $141 | $496 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
47 | $63 | $255 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
36 | $11 | $69 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $63 | $249 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
27 | $102 | $1,127 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
26 | $817 | $5,426 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
26 | $2 | $9 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $42 | $154 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
21 | $277 | $2,419 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
20 | $248 | $929 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
20 | $27 | $126 |
| New patient office visit, complex (60-74 min) | 17 | $176 | $705 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $104 | $468 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
13 | $581 | $2,605 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
12 | $331 | $1,562 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $57 | $370 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
11 | $60 | $348 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.7% high complexity
21.8% medium
74.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$16,507
Total received (2018-2024)
Avg $2,358/year across 7 years
Top 2% in GA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
316
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,041 (54.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,466 (45.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,640
2023
$1,141
2022
$1,263
2021
$970
2020
$589
2019
$1,162
2018
$9,742
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
COLOPLAST CORP
$329
Sumitomo Pharma America, Inc.
$211
Medtronic, Inc.
$155
ABBVIE INC.
$147
Myriad Genetic Laboratories, Inc.
$146
Endo USA, Inc.
$112
UROGEN PHARMA, INC.
$58
Ferring Pharmaceuticals Inc.
$58
Bayer Healthcare Pharmaceuticals Inc.
$49
Ambu Inc.
$45
Astellas Pharma US Inc
$42
Endo Pharmaceuticals Inc.
$35
Boston Scientific Corporation
$32
Dendreon Pharmaceuticals LLC
$31
Janssen Biotech, Inc.
$28
CONMED Corporation
$28
Teleflex LLC
$27
Ethicon US, LLC
$21
PROGENICS PHARMACEUTICALS, INC.
$20
LSI SOLUTIONS INC
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Photocure Inc
$14
CIVCO Medical Instruments
$14
Top 3 companies account for 42.4% of 2024 payments
All-time payments by company (2018-2024) ›
Endo Pharmaceuticals Inc.
$9,333
Coloplast Corp
$711
Myriad Genetic Laboratories, Inc.
$554
COLOPLAST CORP
$551
Boston Scientific Corporation
$527
Astellas Pharma US Inc
$481
Medtronic, Inc.
$413
Sumitomo Pharma America, Inc.
$353
ABBVIE INC.
$336
Intuitive Surgical, Inc.
$314
Dendreon Pharmaceuticals LLC
$302
Blue Earth Diagnostics Limited
$195
Palette Life Sciences, Inc.
$174
UROVANT SCIENCES INC
$138
BOSTON SCIENTIFIC CORPORATION
$132
PFIZER INC.
$129
Olympus America Inc.
$129
Teleflex LLC
$113
Endo USA, Inc.
$112
UROGEN PHARMA, INC.
$106
Covidien LP
$81
Laborie Medical Technologies Corp.
$79
Ferring Pharmaceuticals Inc.
$78
AstraZeneca Pharmaceuticals LP
$71
Bayer Healthcare Pharmaceuticals Inc.
$70
AngioDynamics, Inc.
$68
180 Medical, Inc.
$65
Myovant Sciences Inc.
$64
AbbVie Inc.
$59
Ethicon US, LLC
$58
AbbVie, Inc.
$50
Bayer HealthCare Pharmaceuticals Inc.
$48
Rochester Medical Corporation
$45
Ambu Inc.
$45
Janssen Biotech, Inc.
$45
Travere Therapeutics, Inc.
$36
Allergan Inc.
$36
Antares Pharma, Inc.
$35
CONMED Corporation
$28
Philips Electronics North America Corporation
$24
NeoTract Inc.
$22
Progenics Pharmaceuticals, Inc.
$20
Integra LifeSciences Corporation
$20
PROGENICS PHARMACEUTICALS, INC.
$20
Richard Wolf Medical Instruments Corp.
$20
LSI SOLUTIONS INC
$19
ConvaTec Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
C. R. Bard, Inc. & Subsidiaries
$18
KOELIS Inc.
$18
Agiliti Surgical, Inc.
$18
Axonics Modulation Technologies, Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
SRS Medical Systems, Inc.
$15
PROCEPT BioRobotics Corporation
$15
Photocure Inc
$14
CIVCO Medical Instruments
$14
Merck Sharp & Dohme Corporation
$14
Retrophin, Inc.
$5
Top 3 companies account for 64.2% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · (8584) UroNav · ADSTILADRIN · AIRSEAL · AMS · AMS 700 CXR RTE Kit · AVEED · AquaBeam Robotic System · Axonics r-SNM System · Axumin · BIOFIX · BOTOX · CONTINENCE CARE · CYSVIEW · Da Vinci Surgical System · ECHELON FLEX Stapler · EMS SWISS LITHOCLAST TRIOLOGY · ENTEREG · ERLEADA · EVUSHELD · Echelon Flex · Erleada · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL - FEMALE SUI · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GENTLECATH GLIDE · General - Therapies · Genesis · INTERSTIM · JELMYTO · JNW URTRAC · LIGASURE · LITHOVUE · LUPRON DEPOT · LYNPARZA · LigaSure · LithoVue · Lupron Depot · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Nubeqa · ORGOVYX · Olympus · Olympus Cysto-Resection · PENILE & TESTICULAR RECONSTRUCTN · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · REZUM · SIGNIA · SPACEOAR · SPACEOAR VUE · SPEEDICATH · Sonablate · TITAN · TOVIAZ · Thiola · Titan · Trinity · UROLIFT · UroCuff · UroLift · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in student in an organized health care education/training program and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for student in an organized health care education/training program in GA.
Geographic Context
Student in an organized health care education/training programs within 10 mi
5,005
Per 100K population
468.4
County median income
$91,490
Nearest hospital
PIEDMONT HOSPITAL, INC
3.6 mi
3.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kozinn is a clinical cardiology specialist, with above-average Medicare volume (top 12% in GA), with speaking/promotional industry engagement in the top 2% of GA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kozinn experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kozinn performed 415 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kozinn receive payments from pharmaceutical companies?
Yes. Dr. Kozinn received a total of $16,507 from 59 companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kozinn's costs compare to other student in an organized health care education/training programs in Atlanta?
Dr. Kozinn's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kozinn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Atlanta
Browse student in an organized health care education/training programs in Atlanta ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in GA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in GA
Which GA student in an organized health care education/training programs receive the most from drug and device companies.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology